Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE2008.008.5 (+0.43 %)
PREV CLOSE ( ) 1999.50
OPEN PRICE ( ) 1952.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3713
TODAY'S LOW / HIGH ( )1952.15 2034.95
52 WK LOW / HIGH ( )1163.05 2249.65
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-06 2007
Management Info
- Chairman Neeraj Sharma - Managing Director
Registered Office

Address Unit No. 902, Cyber One,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924

Email cs@stelis.com

Website www.stelis.com

Registrars Details
Not Available
 Listing : BSE, NSE
NEWS
16Jun Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed that the Exchange has received t..
11Jun OneSource Specialty Pharma informs abo
In continuation to its earlier intimation dated June 10, 2025, regarding..
11Jun OneSource partners with Xbrane Biophar
OneSource Specialty Pharma and Xbrane Biopharma AB (Xbrane), a Sweden-he..
10Jun Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed about the subscription of equity..
10Jun OneSource Specialty Pharma’s Bangalo
OneSource Specialty Pharma’s flagship facility in Bangalore, India, ha..
MORE
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit1741.87193.1
Gross Profit 1748.77 -214.55
Operating Profit 2408.653869.57
Net Sales 4774.1412995.89
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  12019.90 (3.17%)
M.Cap ( in Cr)15350.96
Sanofi Cons. Health (BSE)
up  5290.00 (1.79%)
M.Cap ( in Cr)12124.24
Mankind Pharma (BSE)
up  2438.50 (3.17%)
M.Cap ( in Cr)101597.31
Ajanta Pharma (BSE)
up  2701.55 (2.74%)
M.Cap ( in Cr)33452.71
Alkem Laboratories (BSE)
up  4884.45 (1.33%)
M.Cap ( in Cr)57916.69
MORE
Shareholding Pattern
MUTUAL FUNDS/UTI 8.32%
PROMOTERS 34.25%
NON-INSTITUTION 29.3%
FI/BANKS/INSURANCE 2.78%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
LIC MF Healthcare F...1.84
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.